Radiation treatment monitoring with DCE-US in CWR22 prostate tumor xenografts

Abstract

Background

Longitudinal monitoring of potential radiotherapy treatment effects can be determined by dynamic contrast-enhanced ultrasound (DCE-US).

Purpose

To assess functional parameters by means of DCE-US in a murine subcutaneous model of human prostate cancer, and their relationship to dose deposition and time-frame after treatment. A special focus has been placed to evaluate the vascular heterogeneity of the tumor and on the most suitable data analysis approach that reflects this heterogeneity.

Material and Methods

In vivo DCE-US was acquired 24 h and 48 h after radiation treatment with a single dose of 7.5 Gy and 10 Gy, respectively. Tumor vasculature was characterized pixelwise using the Brix pharmacokinetic analysis of the time-intensity curves.

Results

Longitudinal changes were detected (P < 0.001) at 24 h and 48 h after treatment. At 48 h, the eliminating rate constant of the contrast agent from the plasma, k_el, was correlated (P ≤ 0.05) positively with microvessel density (MVD; r_τ = 0.7) and negatively with necrosis (r_τ = –0.6) for the treated group. Furthermore, Ak_ep, a parameter related to transcapillary transport properties, was also correlated to MVD (r_τ = 0.6, P ≤ 0.05).

Conclusion

DCE-US has been shown to detect vascular changes at a very early stage after radiotherapy, which is a great advantage since DCE-US is non-invasive, available at most hospitals, and is low in cost compared to other techniques used in clinical practice.

Keywords

Dynamic contrast-enhanced ultrasound DCE-US ultrasound CWR22 prostate cancer

Get full access to this article

View all access options for this article.

References

Jain

RK.

Delivery of molecular and cellular medicine to solid tumors.

Adv Drug Deliv Rev 2012; 64:353–365.

Udagawa

Birsner

Wood

et al . Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. Cancer Res 2007; 67:2040–2045.

Martin

BJ.

Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.

Semin Radiat Oncol 2013; 23:281–287.

Kluetz

Figg

Dahut

WL.

Angiogenesis inhibitors in the treatment of prostate cancer.

Expert Opin Pharmacother 2010; 11:233–247.

Hudson

Williams

Tremblay-Darveau

et al . Dynamic contrast enhanced ultrasound for therapy monitoring. Eur J Radiol 2015; 84:1650–1657.

Lee

Karshafian

Papanicolau

et al . Quantitative ultrasound for the monitoring of novel microbubble and ultrasound radiosensitization. Ultrasound Med Biol 2012; 38:1212–1221.

Lassau

Bonastre

Kind

et al . Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study. Invest Radiol 2014; 49:794–800.

Yang

Knopp

MV.

Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.

J BioMed Biotechnol 2011;2011:732848,

Agrawal

Nalcioglu

et al . Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer 2009; 115:1363–1380.

10.

Macura

Ouwerkerk

Jacobs

et al . Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics 2006; 26:1719–1734.

11.

Pitre-Champagnat

Leguerney

Bosq

et al . Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization. Invest Radiol 2015; 50:212–217.

12.

Arteaga-Marrero N, Rygh CB, Mainou-Gomez JF, et al. Multimodal approach to assess tumor vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumor xenografts. Contrast Media Mol Imaging 2015;10(6):428–437.

13.

Arteaga-Marrero N, Brekke Rygh C, Mainou-Gomez JF, et al. Radiation treatment monitoring using multimodal functional imaging: PET/CT (₁₈F-Fluoromisonidazole & ₁₈F-Fluorocholine) and DCE-US. J Trans Med 2015;13:383–392.

14.

Brix

Semmler

Port

et al . Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15:621–628.

15.

Daeichin

Bosch

Needles

et al . Subharmonic, non-linear fundamental and ultraharmonic imaging of microbubble contrast at high frequencies. Ultrasound Med Biol 2015; 41:486–497.

16.

Cosgrove

Lassau

Imaging of perfusion using ultrasound.

Eur J Nucl Med Mol Imaging 2010; 37:65–85.

17.

Røe

Seierstad

Kristian

et al . Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions. Neoplasia 2010; 12:818–825.

18.

Griffith

Yeung

et al . Modified brix model analysis of bone perfusion in subjects of varying bone mineral density. J Magn Reson Imaging 2010; 31:1169–1175.

19.

Dietrich

Averkiou

Correas

et al . An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumor perfusion. Ultraschall Med 2012; 33:344–351.

20.

Strouthos

Lampaskis

Sboros

et al . Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2010; 57:1296–1310.

21.

Jingu

Kishimoto

Mizoe

et al . Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC). Radiother Oncol 2011; 98:68–73.

22.

Marusyk

Almendro

Polyak

Intra-tumor heterogeneity: a looking glass for cancer?

Nat Rev Cancer 2012; 12:323–334.

23.

Lassau

Koscielny

Albiges

et al . Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res 2010; 16:1216–1225.

24.

Gauthier

Averkiou

Leen

EL.

Perfusion quantification using dynamic contrast-enhanced ultrasound: the impact of dynamic range and gain on time–intensity curves.

Ultrasonics 2011; 51:102–106.

25.

Takayama

Kishimoto

Hanaoka

et al . ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy. J Magn Reson Imaging 2008; 27:1331–1335.

26.

Baker

Krochak

RJ.

The response of the microvascular system to radiation: a review.

Cancer Invest 1989; 7:287–294.

27.

Hoyt

Umphrey

Lockhart

et al . Ultrasound imaging of breast tumor perfusion and neovascular morphology. Ultrasound Med Biol 2015; 41:2292–2302.